Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

By Lisa Levin
October 18, 8:18 AM
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware.

ADN

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights
October 6, 5:31 PM
Gainers ContraFect (NASDAQ:CFRX) stock rose 17.5% to $0.47 during Friday’s after-market session. The market value of their outstanding…

ADXN

Read More
2 minute read
  • M&A

New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development And Manufacturing Facilities From Talaris Therapeutics; No Financial Terms Disclosed

By Benzinga Newsdesk
October 4, 8:39 AM
New York Blood Center Enterprises (NYBCe) and Talaris Therapeutics, Inc. (NASDAQ:TALS) ("Talaris") announced today NYBCe's acquisition of commercial-scale cell and gene therapy development and manufacturing facilities,

TALS

Read More
1 minute read
  • Asset Sales
  • M&A
  • News

ImmunoFree Inc. Has Acquired Talaris Therapeutics, Inc.’s Tolerance Business; No Financial Terms Disclosed

By Happy Mohamed
August 14, 1:12 PM
ImmunoFree, Inc. announced today that it has acquired all right to FCR001, a cellular therapy product, and the sponsorship of the FREEDOM-1 Study formerly owned by Talaris Therapeutics (TALS). ImmunoFree has assumed all

TALS

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights
July 26, 9:06 AM
Gainers Tilray Brands (NASDAQ:TLRY) shares rose 17.9% to $1.98 during Wednesday’s pre-market session. The company’s market cap stands…

ARMP

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet

By Lisa Levin
June 22, 2:55 PM
U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday. The Dow traded down 0.03% to 33,942.78 while the NASDAQ rose 0.75% to 13,603.24. The S&P 500, also rose, gaining, 0.27% to 4,377.39.

AGLE

Read More
3 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights
June 22, 1:38 PM
Gainers Aeglea BioTherapeutics (NASDAQ:AGLE) shares increased by 369.4% to $0.5 during Thursday’s regular session. Trading volume for Aeglea…

AGLE

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin
June 22, 1:09 PM
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private investment positions.

$APE

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher

By Lisa Levin
June 22, 12:10 PM
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday. The Dow traded down 0.11% to 33,912.98 while the NASDAQ rose 0.54% to 13,574.90. The S&P 500, also rose, gaining, 0.10% to 4,369.87.

AGLE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks

Why Talaris Therapeutics Stock Is Shooting Higher Today

By Vandana Singh
June 22, 11:27 AM
Talaris Therapeutics Inc (NASDAQ: TALS) and Tourmaline Bio, Inc have entered into a definitive agreement for a merger in an all-stock transaction, and the combined company will operate under the name Tourmaline Bio Inc trade on the Nasdaq 

TALS

Posts pagination

1 2 … 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service